Increasing numbers of individuals suffer from post-acute COVID-19 syndrome (PACS),
which manifests with persistent symptoms, the most prevalent being dyspnea, fatigue, and …

Background Tocilizumab blocks pro-inflammatory activity of interleukin-6 (IL-6), involved in
pathogenesis of pneumonia the most frequent cause of death in COVID-19 patients. Methods …

Severe asthma affects about 10% of the population with asthma and is characterized by low
lung function and a high count of blood leukocytes, mainly eosinophils. Various definitions …

Streptococcus pneumoniae related diseases are a leading cause of morbidity and mortality,
especially in children and in the elderly population. It is transmitted to other individuals …

Viral respiratory infections are recognized risk factors for the loss of control of allergic asthma
and the induction of exacerbations, both in adults and children. Severe asthma is more …

Background Biological drugs have been recognized as a breakthrough in the treatment of
severe refractory asthma. This retrospective real-life observational study aims to evaluate the …

Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a safe
and accurate diagnostic procedure used for investigating mediastinal pathologies. It is …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing a massive
outbreak throughout the world. In this period, diseases other than coronavirus disease (COVID-19…

Il mesotelioma è un tumore raro che nasce dalle cellule mesoteliali che rivestono la
superficie delle sierose, nella maggior parte dei casi la partenza è pleurica. Il fattore di rischio …

The novel coronavirus called “Severe Acute Respiratory Syndrome Coronavirus 2”(SARS-CoV-2)
caused an outbreak in December 2019, starting from the Chinese city of Wuhan, in the …